This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Carolyn B. Newhouse | |
|---|---|
| Name | Carolyn B. Newhouse |
| Occupation | Physician, Researcher |
| Known for | Geriatric medicine, Alzheimer's research |
Carolyn B. Newhouse is an American physician and geriatrician noted for clinical work and research in Alzheimer's disease and dementia care. She has been associated with academic medicine, clinical trials, and public health initiatives across institutions and collaborations with advocacy organizations. Her work spans clinical practice, policy engagement, and scholarly publication.
Born and raised in the United States, Newhouse completed undergraduate studies before pursuing medical training at a U.S. medical school affiliated with academic centers such as Johns Hopkins Hospital, Massachusetts General Hospital, Mayo Clinic, University of California, San Francisco and Columbia University Irving Medical Center. She undertook residency and fellowship training in internal medicine and geriatrics at programs connected with Brigham and Women's Hospital, Mount Sinai Hospital (Manhattan), Stanford Health Care, University of Pennsylvania Health System and University of Michigan Medical School. During postgraduate training she engaged with research networks like the National Institutes of Health, Centers for Disease Control and Prevention, Alzheimer's Association, American Geriatrics Society and American Medical Association. Her mentors included clinicians and investigators affiliated with Harvard Medical School, Yale School of Medicine, Johns Hopkins University, Duke University School of Medicine and Northwestern University Feinberg School of Medicine.
Newhouse has held faculty and clinical appointments at academic centers including University of Wisconsin School of Medicine and Public Health, University of California, Los Angeles, University of Pittsburgh School of Medicine, University of Washington School of Medicine and University of Colorado Anschutz Medical Campus. She served as a clinician in hospitals and long-term care settings such as Veterans Health Administration, Kaiser Permanente, Beth Israel Deaconess Medical Center, Rush University Medical Center and Cleveland Clinic. Newhouse participated in multicenter trials coordinated by the National Institute on Aging, Alzheimer's Disease Cooperative Study, ClinicalTrials.gov-registered studies, and collaborations with pharmaceutical companies like Pfizer, Eli Lilly and Company, Roche (company), Biogen, and Johnson & Johnson. She contributed to guideline development with organizations including the World Health Organization, National Academies of Sciences, Engineering, and Medicine, Centers for Medicare & Medicaid Services, Agency for Healthcare Research and Quality and Institute for Healthcare Improvement.
Her research addressed clinical trials, cognitive assessment, pharmacotherapy, caregiver interventions, and health services research published in journals such as The New England Journal of Medicine, JAMA, The Lancet, JAMA Neurology, Neurology (journal), Annals of Internal Medicine, BMJ, Alzheimer's & Dementia, and Journal of the American Geriatrics Society. She reported findings on diagnostic criteria linked to work by researchers at National Institute of Neurological Disorders and Stroke, Rush Alzheimer's Disease Center, Mayo Clinic Alzheimer’s Disease Research Center, Massachusetts Alzheimer's Disease Research Center, and UC San Diego Shiley-Marcos Alzheimer’s Disease Research Center. Newhouse collaborated with investigators affiliated with Columbia University Irving Medical Center, Johns Hopkins School of Medicine, Massachusetts General Hospital, Stanford University School of Medicine and University College London on topics intersecting with biomarkers from studies at Alzheimer's Disease Neuroimaging Initiative, genetic analyses referencing APOE research, and health policy implications connected to Medicare (United States), Affordable Care Act deliberations and National Alzheimer's Project Act priorities.
Newhouse received recognition from professional societies and institutions including the American Geriatrics Society, Gerontological Society of America, Alzheimer's Association, National Institute on Aging, Society of General Internal Medicine, Association of American Medical Colleges, and university-level awards from places like University of Wisconsin–Madison, University of California, Yale University, and Harvard Medical School. Her honors included named lectureships, lifetime achievement acknowledgments, and grants from funders such as the National Institutes of Health, Patient-Centered Outcomes Research Institute, Robert Wood Johnson Foundation, Gates Foundation, and private foundations supporting dementia research.
Newhouse balanced clinical work with academic mentorship, training fellows and residents associated with programs at Harvard Medical School, Yale School of Medicine, University of Michigan, University of Pennsylvania, and UCSF. Colleagues and mentees have gone on to positions at institutions such as Mayo Clinic, Massachusetts General Hospital, Johns Hopkins University, Duke University, and Columbia University, reflecting her influence on subsequent generations. Her legacy includes contributions to clinical practice, trial methodology, caregiver resources, and interdisciplinary collaborations spanning neurology, psychiatry, nursing, and public health, with continued impact through citations in literature from The Lancet Neurology, JAMA Neurology, Annals of Neurology, and policy briefs from National Academy of Medicine and World Health Organization.
Category:American physicians Category:Geriatricians Category:Alzheimer's disease researchers